This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • ImplemeNtation oF demOnstration pRoject for Health...
Clinical trial

ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1

Read time: 1 mins
Last updated:1st Oct 2015

The goal of this study is to learn about the patient and provider perceptions, priorities, preferences, and willingness to use/prescribe anticoagulation as a stroke prevention therapy in patients with atrial fibrillation. Qualitative interviews will be performed with atrial fibrillation patients and providers caring for atrial fibrillation patients. The investigators want to understand the factors that influence decision-making about anticoagulation medications, and to gain insight into patients' and providers' knowledge of the risk of stroke and bleeding associated with oral anticoagulation. This feedback will help provide better education to providers caring for patients with atrial fibrillation and better care to patients with atrial fibrillation by developing tools to optimize the appropriate use of oral anticoagulation for patients with atrial fibrillation.

Study Type: Observational

Time Perspective: Prospective

Official Title: ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1

Estimated Enrollment: 110

Study Start Date: October 2015

Estimated Study Completion Date: December 2015

Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)

Groups/Cohorts:

Patients
Patients of consenting providers will complete a short survey and interview.

Providers
Physicians treating patients with atrial fibrillation will complete a short survey and interview.

 

Category Value
Study start date 2015-10-01

View full details